Journal of Fluorine Chemistry, volume 239, pages 109639

Next generation organofluorine containing blockbuster drugs

Jianlin Han 1
Attila Márió Remete 2
Luca S Dobson 3
Lorand Kiss 2
Kunisuke Izawa 4
Hiroki Moriwaki 4
Vadim A. Soloshonok 5, 6
David O’Hagan 3
Publication typeJournal Article
Publication date2020-11-01
Quartile SCImago
Q3
Quartile WOS
Q3
Impact factor1.9
ISSN00221139
Organic Chemistry
Biochemistry
Inorganic Chemistry
Physical and Theoretical Chemistry
Environmental Chemistry
Abstract
Abstract The role of organo-fluorine compounds in modern health, food and energy related industries is widely-appreciated. The unique properties that fluorine imparts to organic molecules, stemming from its high electronegativity and stability when bound to carbon, finds it increasingly being used in the development of new bioactivities. Around 25 % of the current blockbuster drugs contain fluorine and this number is increasing to well above 30 % for recent FDA approvals. In this Review we highlight a selection of the most successful organo-fluorine drugs, that have achieved blockbuster status, namely, sitagliptin (diabetes), sofosbuvir (hepatitis C), emtricitabine (HIV), glecaprevir/pibrentasvir (hepatitis C), elvitegravir (HIV), dolutegravir (HIV), bictegravir (HIV), efavirenz (HIV), enzalutamide (prostate cancer), aubagio (immunomodulatory) and paliperidone palmitate (schizophrenia). For each compound we discuss their discovery, their relevant disease state and how they are made, emphasizing the source of fluorine-containing moieties, and where known, their mode of action.

Top-30

Citations by journals

2
4
6
8
10
12
14
16
18
20
Journal of Fluorine Chemistry
19 publications, 9.9%
European Journal of Organic Chemistry
12 publications, 6.25%
Chemistry - A European Journal
11 publications, 5.73%
Organic Letters
10 publications, 5.21%
Journal of Organic Chemistry
9 publications, 4.69%
Chemical Record
8 publications, 4.17%
Beilstein Journal of Organic Chemistry
6 publications, 3.13%
Angewandte Chemie
6 publications, 3.13%
Molecules
6 publications, 3.13%
Angewandte Chemie - International Edition
6 publications, 3.13%
Organic and Biomolecular Chemistry
4 publications, 2.08%
Chinese Chemical Letters
4 publications, 2.08%
Organic Chemistry Frontiers
4 publications, 2.08%
Advanced Synthesis and Catalysis
3 publications, 1.56%
Pharmaceuticals
3 publications, 1.56%
Tetrahedron
3 publications, 1.56%
Asian Journal of Organic Chemistry
3 publications, 1.56%
Chemical Communications
3 publications, 1.56%
Chemical Science
3 publications, 1.56%
Russian Chemical Bulletin
2 publications, 1.04%
Symmetry
2 publications, 1.04%
Molecular Diversity
2 publications, 1.04%
Mendeleev Communications
2 publications, 1.04%
Helvetica Chimica Acta
2 publications, 1.04%
New Journal of Chemistry
2 publications, 1.04%
Synlett
2 publications, 1.04%
Nature Chemistry
2 publications, 1.04%
ChemistrySelect
2 publications, 1.04%
Current Green Chemistry
1 publication, 0.52%
2
4
6
8
10
12
14
16
18
20

Citations by publishers

10
20
30
40
50
60
70
Wiley
62 publications, 32.29%
Elsevier
41 publications, 21.35%
American Chemical Society (ACS)
26 publications, 13.54%
Royal Society of Chemistry (RSC)
20 publications, 10.42%
Springer Nature
13 publications, 6.77%
Multidisciplinary Digital Publishing Institute (MDPI)
12 publications, 6.25%
Beilstein-Institut
6 publications, 3.13%
Thieme
3 publications, 1.56%
Taylor & Francis
2 publications, 1.04%
Bentham Science
1 publication, 0.52%
Shanghai Institute of Organic Chemistry
1 publication, 0.52%
Frontiers Media S.A.
1 publication, 0.52%
Cold Spring Harbor Laboratory
1 publication, 0.52%
International Union of Crystallography (IUCr)
1 publication, 0.52%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 0.52%
10
20
30
40
50
60
70
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Han J. et al. Next generation organofluorine containing blockbuster drugs // Journal of Fluorine Chemistry. 2020. Vol. 239. p. 109639.
GOST all authors (up to 50) Copy
Han J., Remete A. M., Dobson L. S., Kiss L., Izawa K., Moriwaki H., Soloshonok V. A., O’Hagan D. Next generation organofluorine containing blockbuster drugs // Journal of Fluorine Chemistry. 2020. Vol. 239. p. 109639.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.jfluchem.2020.109639
UR - https://doi.org/10.1016/j.jfluchem.2020.109639
TI - Next generation organofluorine containing blockbuster drugs
T2 - Journal of Fluorine Chemistry
AU - Han, Jianlin
AU - Remete, Attila Márió
AU - Dobson, Luca S
AU - Kiss, Lorand
AU - Izawa, Kunisuke
AU - Moriwaki, Hiroki
AU - Soloshonok, Vadim A.
AU - O’Hagan, David
PY - 2020
DA - 2020/11/01 00:00:00
PB - Elsevier
SP - 109639
VL - 239
SN - 0022-1139
ER -
BibTex
Cite this
BibTex Copy
@article{2020_Han,
author = {Jianlin Han and Attila Márió Remete and Luca S Dobson and Lorand Kiss and Kunisuke Izawa and Hiroki Moriwaki and Vadim A. Soloshonok and David O’Hagan},
title = {Next generation organofluorine containing blockbuster drugs},
journal = {Journal of Fluorine Chemistry},
year = {2020},
volume = {239},
publisher = {Elsevier},
month = {nov},
url = {https://doi.org/10.1016/j.jfluchem.2020.109639},
pages = {109639},
doi = {10.1016/j.jfluchem.2020.109639}
}
Found error?